<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/94CCACE0-5BC5-46BC-AC61-B3F202D59C53"><gtr:id>94CCACE0-5BC5-46BC-AC61-B3F202D59C53</gtr:id><gtr:name>Open University of Israel</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AD4854E1-71AF-4687-93A9-5F05968D34DB"><gtr:id>AD4854E1-71AF-4687-93A9-5F05968D34DB</gtr:id><gtr:name>University of Pisa</gtr:name><gtr:address><gtr:line1>University of Pisa</gtr:line1><gtr:line2>Lungarno Pacinotti 43</gtr:line2><gtr:line4>Pisa</gtr:line4><gtr:postCode>I 56126</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Dept of Medicine</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/94CCACE0-5BC5-46BC-AC61-B3F202D59C53"><gtr:id>94CCACE0-5BC5-46BC-AC61-B3F202D59C53</gtr:id><gtr:name>Open University of Israel</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AD4854E1-71AF-4687-93A9-5F05968D34DB"><gtr:id>AD4854E1-71AF-4687-93A9-5F05968D34DB</gtr:id><gtr:name>University of Pisa</gtr:name><gtr:address><gtr:line1>University of Pisa</gtr:line1><gtr:line2>Lungarno Pacinotti 43</gtr:line2><gtr:line4>Pisa</gtr:line4><gtr:postCode>I 56126</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/37B9853E-9514-4E8D-A985-18621B05BD4B"><gtr:id>37B9853E-9514-4E8D-A985-18621B05BD4B</gtr:id><gtr:firstName>Isabelle</gtr:firstName><gtr:surname>Leclerc</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/CFAA70A9-58F6-4917-9260-A4338890F14F"><gtr:id>CFAA70A9-58F6-4917-9260-A4338890F14F</gtr:id><gtr:firstName>Guy</gtr:firstName><gtr:otherNames>Allen</gtr:otherNames><gtr:surname>Rutter</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/57C2D6A9-5D51-45C3-A87B-E27A5A9F554C"><gtr:id>57C2D6A9-5D51-45C3-A87B-E27A5A9F554C</gtr:id><gtr:firstName>Gabriela</gtr:firstName><gtr:surname>da Silva Xavier</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FK001981%2F1"><gtr:id>F7D30B0E-5FF5-42F1-A641-BEA4393FEB32</gtr:id><gtr:title>Roles of GWA genes in controlling pancreatic beta cell function and mass.</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/K001981/1</gtr:grantReference><gtr:abstractText>Diabetes mellitus affects more than 20 m Europeans and 300 m individuals worldwide. The complications of the disease, including blindness, kidney failure, cardiovascular disease and cancer, drastically reduce the quality of life of sufferers, and consume almost 10 % of health care costs in most westernised nations. The most common form, Type 2 diabetes (T2D), has both genetic and environmental causes, and is particularly prevalent in the overweight. Insulin is the chief &amp;quot;anabolic&amp;quot; hormone responsible for restoring blood sugar levels after a meal and its absence - as well as a failure to act appropriately in T2D - underlies the symptoms of this disease. 

Therapeutic approaches towards T2D have relied in the past on enhancing the actions of insulin, and more recently on stimulating insulin secretion. However, none of the existing therapies reverse the progressive loss of functional beta cells and hence the gradual worsening of disease symptoms. New strategies aimed at restoring an adequate number of normally functioning beta-cells are thus urgently sought. 

Studies made possible by the human genome project, completed in 2000, and the subsequent mapping of genetic variants (single nucleotide polymorphisms) in man have permitted in the last four years &amp;quot;Genome wide association studies&amp;quot; (GWAS) for T2D. These have identified several genetic variants whose inheritance is associated with an increased risk of diabetes. The identification of these genes, most of which influence insulin production, provides both improved powers of prediction and, just as excitingly, potential new molecular targets for drug treatment. 

Our proposed studies will involve two complementary areas aimed at obtaining a fuller understanding of how a subset of T2D genes affect disease risk. Our first aim is to examine in detail the role in the pancreatic beta cell of five genes identified at two novel GWAS &amp;quot;loci&amp;quot; in the human genome. We shall use both a new mouse model engineered to allow genes of interest to be selectively deleted in the pancreatic beta cell, and classical biochemical and mouse genetic approaches to examine the roles of the implicated gene products. 

Secondly, we seek to examine the means through which a tumour suppressor termed LKB1, which controls beta cell growth, may be modulated by two relatively well-studied GWA genes for T2D. Inactivation of LKB1 in man leads to a rare form of cancer termed Peutz-Jeghers syndrome. Remarkably, when the LKB1 gene is deleted selectively in the beta cell, mutant mice experience a substantial expansion in beta cell mass and enjoy increased insulin production and improved glucose homeostasis. Importantly, insulin release only occurs when blood glucose levels are high, avoiding the risk of a dangerous &amp;quot;undershoot&amp;quot; in glucose (hypoglycaemia). Here, we shall dissect the signalling pathways lying downstream of LKB1, and explore the potential roles of the GWA genes TCF7L2 and SLC30A8.</gtr:abstractText><gtr:technicalSummary>Type 2 diabetes (T2D) represents an epidemic of the 21 st century and consumes almost 10 % of the health care budgets in westernised societies. Progressive pancreatic beta cell failure is a sine qua non for the development of the disease. Whilst diabetes risk is markedly increased by factors including obesity, T2D shows a strong element of heritability. Correspondingly, recent genome wide association studies have identified loci affecting disease risk, the majority of which alter insulin production rather than action. 

Our laboratories have been in the vanguard of those seeking to dissect the underlying molecular mechanisms. Under Aim 1, we will explore the roles in the beta cell of five genes found at two novel risk loci, selected for study using defined criteria. The first locus, close to a single nucleotide polymorphism (SNP) on chromosome 11, includes two genes: CENTD2, encoding the GTPase activating protein Arap1, and STARD10 encoding a phospholipid transfer protein of presently unknown function. The second locus, on chromosome 9, encodes a cluster of genes implicated in cell cycle control: CDKN2A, CDKN2B and p14Arf, and a non-coding RNA termed ANRIL predicted to regulate the expression of the three former genes. In each case we shall use newly-available human beta cell lines, primary mouse and human islets, and a novel transgenic mouse (INS-Tva) which allows targeted delivery of shRNAs/miRNAs or cDNAs to the beta cell in vivo. In Aim 2 we shall dissect the mechanisms of action of the tumour suppressor LKB1, whose deletion in the beta cell causes a considerable increase in beta cell mass and enhances insulin release. We shall focus on the downstream roles of two well-established GWA genes: TCF7L2, a target of Wnt signalling, and SLC30A8, encoding the secretory granule zinc transporter ZnT8. The Programme will thus provide important insights into the mechanisms controlling beta cell mass and function, and potentially new avenues for therapy.</gtr:technicalSummary><gtr:potentialImpactText>Impact Summary
The research proposed here is likely to benefit both the general population, in terms of improvements in healthcare, as well as the UK Pharmaceutical industry.

1. The general population of the UK. Type 2 diabetes affects ~3 m UK subjects and ~30 m Europeans (mean prevalence 8.4%; http://www.euphix.org/object_document/o4858n27165.html). These values are predicted to grow further in an &amp;quot;epidemic&amp;quot; driven by increasingly sedentary lifestyles and obesity. The complications of the disease include stroke, retinopathy, neuropathy, renal failure, cardiovascular disease and now cancer. The increased prevalence of this disease was recently predicted to contribute to a lowered overall life expectancy in the UK (http://www.independent.co.uk/life-style/health-and-wellbeing/health-news/diabetes-may-cause-first-fall-in-life-expectancy-for-200-years-966914.html) for the first time in 200 years. Treatment of diabetes is estimated to cost ~&amp;pound;8000 per year per patient, or &amp;pound; 24 billion in total: diabetic patients are 3.5 times more likely to be admitted for hospital treatment than the rest of the population (http://www.physorg.com/news151077389.html). These direct economic costs together account for 7-13 % of health care costs in most developed societies (IDF Diabetes Atlas, 2003) and are further aggravated by increased absenteeism and decreased individual productivity (ADA: Diabetic Care 31, 596, 2008). 

Pancreatic beta-cell loss or dysfunction are cardinal elements of diabetes mellitus, and strategies to rejuvenate or replace these cells, as explored here, are likely to be key to the development of new therapeutic approaches for this disease and its complications. 
In particular this work will address roadblocks in diabetes research as identified recently by the European Commission's Support Action &amp;quot;DIAMAP: A Road Map for Diabetes in Europe&amp;quot; (http://www.diamap.eu/; 7th Sep, 2010) including the development of: &amp;quot;novel therapies based on beta cell mass and function&amp;quot; a &amp;quot;a lack of appropriate models that mimic the human condition&amp;quot;. 

2. The UK Pharmaceutical Industry. The global market for anti-diabetes drugs is estimated to be worth ~$30 billion. Following its joint Workshop with the Association of British Pharmaceutical Industries (ABPI) in March 2011, the MRC concluded that pancreatic beta cell biology should become a Strategic Priority, alongside Stratified Medicine. The present application addresses both of these areas. 

New drug targets and leads are desperately needed for the Pharmaceutical industry to produce novel approaches to diabetes treatment. By addressing highly promising new targets, including those identified by GWA screens, and others likely to contribute to beta cell dysfunction, the proposed study will enhance feeds of new Intellectual Property to this sector. As a member of the trans-European diabetes research network &amp;quot;IMIDIA&amp;quot; (http://www.imidia.org/) the PI already interacts with several UK and Europe-based companies (eg Astra Zeneca, Sanofi Aventis, Boehringer-Ingelheim, Novo Nordisk and Novartis), and has established a collaboration with Pfizer (US) to initiate high throughput screens for small molecule regulators of LKB1, which may control beta cell mass. Similarly, with Cenix, an SME based in Dresden, he has begun a collaboration to use genome-wide RNAis screens to identify endogenous regulators of GWA genes including TCF7L2 and ZnT8. 

Each of the three research fellows directly involved in the project will enhance their professional skills with training in basic biomedical research and thus develop their skill set for application in both the academic and commercial sectors.</gtr:potentialImpactText><gtr:fund><gtr:end>2017-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1514615</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Pisa</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>Piero Marchetti (Pisa)</gtr:description><gtr:id>484D4738-D5B4-42D1-8FF9-D864FFDB5F85</gtr:id><gtr:impact>Sorcin links pancreatic ? cell lipotoxicity to ER Ca2+ stores - Marmugi A et al - PMID: 26822088
Hypoxia lowers SLC30A8/ZnT8 expression and free cytosolic Zn2+ in pancreatic beta cells. Gerber PA et al PMID: 24865615 
Incretin-modulated beta cell energetics in intact islets of Langerhans. Hodson DJ et al - PMID: 24766140 
ADCY5 couples glucose to insulin secretion in human islets. Hodson DJ et al PMID: 24740569 
Lipotoxicity disrupts incretin-regulated human ? cell connectivity. Hodson DJ et al - PMID: 24018562</gtr:impact><gtr:outcomeId>56d5b0adbc26c0.90682469-1</gtr:outcomeId><gtr:partnerContribution>experiments for publications</gtr:partnerContribution><gtr:piContribution>experiments for publications</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Open University of Israel</gtr:collaboratingOrganisation><gtr:country>Israel, State of</gtr:country><gtr:description>Yuval Dor (Israel)</gtr:description><gtr:id>90CA4AE2-5652-4D33-8788-A3CED985E49D</gtr:id><gtr:impact>LKB1 and AMPK differentially regulate pancreatic ?-cell identity - Kone M1 et al - FASEB J. 2014 Nov;28(11):4972-85. doi: 10.1096/fj.14-257667. Epub 2014 Jul 28.

Loss of Liver Kinase B1 (LKB1) in Beta Cells Enhances Glucose-stimulated Insulin Secretion Despite Profound Mitochondrial Defects.
Swisa A1et al - J Biol Chem. 2015 Aug 21;290(34):20934-46. doi: 10.1074/jbc.M115.639237. Epub 2015 Jul 2.</gtr:impact><gtr:outcomeId>56d5a7f3a97ba9.17973559-1</gtr:outcomeId><gtr:partnerContribution>Experiments for publications</gtr:partnerContribution><gtr:piContribution>Experiments for publications</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>B3C96584-7E42-4B22-AC6F-4BA71AEAF720</gtr:id><gtr:title>LKB1 and AMPK differentially regulate pancreatic beta cell fate</gtr:title><gtr:parentPublicationTitle>DIABETOLOGIA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b929cb193e0b334233514fb48bf7a4ad"><gtr:id>b929cb193e0b334233514fb48bf7a4ad</gtr:id><gtr:otherNames>Rutter G. A.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>54624d9548f397.63775495</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>65FB06A9-F757-442C-A061-F9B3F5E671D9</gtr:id><gtr:title>LKB1 and AMPKa1 are required in pancreatic alpha cells for the normal regulation of glucagon secretion and responses to hypoglycemia.</gtr:title><gtr:parentPublicationTitle>Molecular metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c30fc7fc139ea2c7b5c5ae2c8e2ef60"><gtr:id>2c30fc7fc139ea2c7b5c5ae2c8e2ef60</gtr:id><gtr:otherNames>Sun G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2212-8778</gtr:issn><gtr:outcomeId>56c458e7de2e60.75565527</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB2D9EBC-7515-4B51-866A-A8C1BB981066</gtr:id><gtr:title>MiRNAs in ?-Cell Development, Identity, and Disease.</gtr:title><gtr:parentPublicationTitle>Frontiers in genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c0b3700d317c54dc87e750f2b53bdc92"><gtr:id>c0b3700d317c54dc87e750f2b53bdc92</gtr:id><gtr:otherNames>Martinez-Sanchez A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1664-8021</gtr:issn><gtr:outcomeId>5a2fcd20420ea5.11348843</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>119987F8-9602-4930-9BBF-091E7549F7C4</gtr:id><gtr:title>Roles of the type 2 diabetes-associated gene products Arap1 and StarD10 in the control of insulin secretion</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cac9a80dc0012e0c78e9e9682078ce38"><gtr:id>cac9a80dc0012e0c78e9e9682078ce38</gtr:id><gtr:otherNames>Carrat, G.R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>546243651759f4.08261203</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FEA29D13-C47A-4D0B-83B5-FF4108205C76</gtr:id><gtr:title>Cell biology. Pancreas micromanages autophagy.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/683c3206afadea563aa753fcbd3ff3dc"><gtr:id>683c3206afadea563aa753fcbd3ff3dc</gtr:id><gtr:otherNames>Rutter GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>56c458e842c462.19638157</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B77A223-8F17-4CC7-91AD-692BB28342E4</gtr:id><gtr:title>Disallowance of Acot7 in ?-Cells Is Required for Normal Glucose Tolerance and Insulin Secretion.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c0b3700d317c54dc87e750f2b53bdc92"><gtr:id>c0b3700d317c54dc87e750f2b53bdc92</gtr:id><gtr:otherNames>Martinez-Sanchez A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>56c458ebb3e0a8.89371381</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75685D0C-0DDA-4924-8EBF-CFEFD9382689</gtr:id><gtr:title>Metformin activates a duodenal Ampk-dependent pathway to lower hepatic glucose production in rats.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e9cf277d2bf7e306d9cf9fa8e8e3c8b"><gtr:id>8e9cf277d2bf7e306d9cf9fa8e8e3c8b</gtr:id><gtr:otherNames>Duca FA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>56c458e8c85b09.54296199</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FBB9454F-F650-445F-94D1-E21932C7E0B8</gtr:id><gtr:title>Defects in mitophagy promote redox-driven metabolic syndrome in the absence of TP53INP1.</gtr:title><gtr:parentPublicationTitle>EMBO molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/610b8a9cee263296fb4c4d0f1a458569"><gtr:id>610b8a9cee263296fb4c4d0f1a458569</gtr:id><gtr:otherNames>Seillier M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1757-4676</gtr:issn><gtr:outcomeId>56c458e8f1c2b9.62174974</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3AF58E24-28C2-48CD-BDF3-4187BC65164B</gtr:id><gtr:title>A red-shifted photochromic sulfonylurea for the remote control of pancreatic beta cell function.</gtr:title><gtr:parentPublicationTitle>Chemical communications (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a477df8754c6ae6088f89cfa0aa69d6"><gtr:id>6a477df8754c6ae6088f89cfa0aa69d6</gtr:id><gtr:otherNames>Broichhagen J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1359-7345</gtr:issn><gtr:outcomeId>56c458e8777ab7.81765521</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E85506B1-9E87-4D9B-8DA0-D1057CCE4E35</gtr:id><gtr:title>Selective disruption of Tcf7l2 in the pancreatic ? cell impairs secretory function and lowers ? cell mass.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f40e1e64032af61ab455c03a6977b343"><gtr:id>f40e1e64032af61ab455c03a6977b343</gtr:id><gtr:otherNames>Mitchell RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>doi_55f94d94dc6b68c4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA4A2BF4-2E00-4C8C-8F34-320A42FB7462</gtr:id><gtr:title>Defective glucose homeostasis in mice inactivated selectively for Tcf7l2 in the adult beta cell with an Ins1-controlled Cre</gtr:title><gtr:parentPublicationTitle>DIABETOLOGIA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f81bd439aed8b669dbd81916f877bb02"><gtr:id>f81bd439aed8b669dbd81916f877bb02</gtr:id><gtr:otherNames>Xavier G. da Silva</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>54623b64d41381.02208714</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DAF79B7E-D3D4-405C-8FB0-DCB25BD5920C</gtr:id><gtr:title>The Zinc Transporter Slc30a8/ZnT8 Is Required in a Subpopulation of Pancreatic a-Cells for Hypoglycemia-induced Glucagon Secretion.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f799243eb7ba625afe63306110bb4db4"><gtr:id>f799243eb7ba625afe63306110bb4db4</gtr:id><gtr:otherNames>Solomou A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>56c458e97922d2.27252509</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B1F93C9B-11AC-40EE-92B9-D172B23B490F</gtr:id><gtr:title>Corrigendum: Metformin activates a duodenal Ampk-dependent pathway to lower hepatic glucose production in rats.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e9cf277d2bf7e306d9cf9fa8e8e3c8b"><gtr:id>8e9cf277d2bf7e306d9cf9fa8e8e3c8b</gtr:id><gtr:otherNames>Duca FA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>56c458ebdce806.07292894</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43A5EF4C-0551-449D-A2EB-44EDBEC45690</gtr:id><gtr:title>Beta cell connectivity in pancreatic islets: a type 2 diabetes target?</gtr:title><gtr:parentPublicationTitle>Cellular and molecular life sciences : CMLS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/683c3206afadea563aa753fcbd3ff3dc"><gtr:id>683c3206afadea563aa753fcbd3ff3dc</gtr:id><gtr:otherNames>Rutter GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1420-682X</gtr:issn><gtr:outcomeId>5460fd7c23d886.37877263</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3BFC96D9-4989-4923-BEA8-A789E1DAAFE8</gtr:id><gtr:title>Sarco(endo)plasmic reticulum ATPase is a molecular partner of Wolfram syndrome 1 protein, which negatively regulates its expression.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fbbc8d3fa6b17f68583334ae7aa43fc5"><gtr:id>fbbc8d3fa6b17f68583334ae7aa43fc5</gtr:id><gtr:otherNames>Zatyka M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>5460fd7bb53573.96599390</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>866592E0-7600-4EC8-BC59-6821EC8034C5</gtr:id><gtr:title>Dual-modal magnetic resonance/fluorescent zinc probes for pancreatic ?-cell mass imaging.</gtr:title><gtr:parentPublicationTitle>Chemistry (Weinheim an der Bergstrasse, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/414503dcfa8825708ac78a77d4cc1b78"><gtr:id>414503dcfa8825708ac78a77d4cc1b78</gtr:id><gtr:otherNames>Stasiuk GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0947-6539</gtr:issn><gtr:outcomeId>56c458e8a392d0.51458290</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F4CE99D-C24E-4619-93BF-F842F6FED3EE</gtr:id><gtr:title>Modeling Type 2 Diabetes GWAS Candidate Gene Function in hESCs.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/683c3206afadea563aa753fcbd3ff3dc"><gtr:id>683c3206afadea563aa753fcbd3ff3dc</gtr:id><gtr:otherNames>Rutter GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>5aa165ce579085.40409021</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8F86EE7B-313D-4CF3-AA4B-68E685788131</gtr:id><gtr:title>LKB1 and AMPK differentially regulate pancreatic ?-cell identity.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d0eaddaf15e6043e0522b5cf5826ebc"><gtr:id>8d0eaddaf15e6043e0522b5cf5826ebc</gtr:id><gtr:otherNames>Kone M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>5453c523399671.63933763</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91F5B71B-1E60-4F6F-A734-2976F6387A4F</gtr:id><gtr:title>DICER Inactivation Identifies Pancreatic ?-Cell &amp;quot;Disallowed&amp;quot; Genes Targeted by MicroRNAs.</gtr:title><gtr:parentPublicationTitle>Molecular endocrinology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c0b3700d317c54dc87e750f2b53bdc92"><gtr:id>c0b3700d317c54dc87e750f2b53bdc92</gtr:id><gtr:otherNames>Martinez-Sanchez A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0888-8809</gtr:issn><gtr:outcomeId>56c458e9257627.18188481</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>187D5001-6BE1-461E-8001-B7672B31DA09</gtr:id><gtr:title>MiR-184 expression is regulated by AMPK in pancreatic islets.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c0b3700d317c54dc87e750f2b53bdc92"><gtr:id>c0b3700d317c54dc87e750f2b53bdc92</gtr:id><gtr:otherNames>Martinez-Sanchez A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>5aa165cc45f001.73981649</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EDC25588-F4B2-4733-BBB6-03AEE41CBF6F</gtr:id><gtr:title>Chronic Activation of ?2 AMPK Induces Obesity and Reduces ? Cell Function.</gtr:title><gtr:parentPublicationTitle>Cell metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/22e33ee43300ac2c2ff3ac2ccf856911"><gtr:id>22e33ee43300ac2c2ff3ac2ccf856911</gtr:id><gtr:otherNames>Yavari A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1550-4131</gtr:issn><gtr:outcomeId>5aa165ce9e0aa7.75833154</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AEDC5AC2-76E8-42A4-B8E2-B6C854859616</gtr:id><gtr:title>ADCY5 couples glucose to insulin secretion in human islets.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a95ae9ae535288f10635d5864ecb10f"><gtr:id>3a95ae9ae535288f10635d5864ecb10f</gtr:id><gtr:otherNames>Hodson DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>5460fd79c951d3.98967023</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7122B3D-456D-4BEF-97B0-3D3467FB8DF9</gtr:id><gtr:title>Hyperglycemia-Induced Changes in ZIP7 and ZnT7 Expression Cause ZnRelease From the Sarco(endo)plasmic Reticulum and Mediate ER Stress in the Heart.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ef18185e375c6dfbc119d9933eb215b"><gtr:id>2ef18185e375c6dfbc119d9933eb215b</gtr:id><gtr:otherNames>Tuncay E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>5a2fcd972537c0.33595581</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B4DDD84-2CBE-4CB3-9F60-ECBF1A12A479</gtr:id><gtr:title>Changes in microRNA expression during differentiation of embryonic and induced pluripotent stem cells to definitive endoderm.</gtr:title><gtr:parentPublicationTitle>Gene expression patterns : GEP</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/01f5766d18ea51598977c1f1bc2a7d4c"><gtr:id>01f5766d18ea51598977c1f1bc2a7d4c</gtr:id><gtr:otherNames>Francis N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1567-133X</gtr:issn><gtr:outcomeId>56c458ea7882a5.13322539</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60D81F81-5C85-4866-895B-2809A75059A9</gtr:id><gtr:title>Pancreatic ?-cell identity, glucose sensing and the control of insulin secretion.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/683c3206afadea563aa753fcbd3ff3dc"><gtr:id>683c3206afadea563aa753fcbd3ff3dc</gtr:id><gtr:otherNames>Rutter GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>56c458e81127b5.35980483</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>344FC644-4C94-4135-98DA-CFFC849D2AA8</gtr:id><gtr:title>Manipulation and Measurement of AMPK Activity in Pancreatic Islets.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c0b3700d317c54dc87e750f2b53bdc92"><gtr:id>c0b3700d317c54dc87e750f2b53bdc92</gtr:id><gtr:otherNames>Martinez-Sanchez A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>5aa165cc831ac9.74858451</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C333D02-A683-46D3-94CC-E19A2FB9DF1A</gtr:id><gtr:title>Mitochondrial and ER-targeted eCALWY probes reveal high levels of free Zn2+.</gtr:title><gtr:parentPublicationTitle>ACS chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c35926d60205c3f93cd6d795fb817389"><gtr:id>c35926d60205c3f93cd6d795fb817389</gtr:id><gtr:otherNames>Chabosseau P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1554-8929</gtr:issn><gtr:outcomeId>585d76bdc0d358.64812598</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>288E132F-18CB-4E39-98E3-44A44F9E9531</gtr:id><gtr:title>The Peutz-Jeghers kinase LKB1 suppresses polyp growth from intestinal cells of a proglucagon-expressing lineage in mice.</gtr:title><gtr:parentPublicationTitle>Disease models &amp; mechanisms</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a08d793991e0cee7394c11e4513df961"><gtr:id>a08d793991e0cee7394c11e4513df961</gtr:id><gtr:otherNames>Zac-Varghese S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1754-8403</gtr:issn><gtr:outcomeId>5453c6856babc8.55871844</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>741492A8-8554-4B0E-9E0B-1D7BEEB1AC40</gtr:id><gtr:title>Diabetes: Controlling the identity of the adult pancreatic ? cell.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/683c3206afadea563aa753fcbd3ff3dc"><gtr:id>683c3206afadea563aa753fcbd3ff3dc</gtr:id><gtr:otherNames>Rutter GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1759-5029</gtr:issn><gtr:outcomeId>5a34f306327eb0.14222279</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0848AD59-8105-4304-9BCE-30C9480934AC</gtr:id><gtr:title>Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) and Endolysosomal Two-pore Channels Modulate Membrane Excitability and Stimulus-Secretion Coupling in Mouse Pancreatic ? Cells.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b59995dcbd944cae7596b1f371e5ac1f"><gtr:id>b59995dcbd944cae7596b1f371e5ac1f</gtr:id><gtr:otherNames>Arredouani A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>56c458e9a02766.45214666</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4EE530E-93B4-437B-A784-66F3486E5EEC</gtr:id><gtr:title>Local and regional control of calcium dynamics in the pancreatic islet.</gtr:title><gtr:parentPublicationTitle>Diabetes, obesity &amp; metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/683c3206afadea563aa753fcbd3ff3dc"><gtr:id>683c3206afadea563aa753fcbd3ff3dc</gtr:id><gtr:otherNames>Rutter GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1462-8902</gtr:issn><gtr:outcomeId>5aa165cd49f9d4.16202697</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F33EA25-E76E-457F-81C9-113DDB8A6611</gtr:id><gtr:title>Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells.</gtr:title><gtr:parentPublicationTitle>Molecular metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a3a6ce1917cf4804fa0bfdb5e45de00"><gtr:id>6a3a6ce1917cf4804fa0bfdb5e45de00</gtr:id><gtr:otherNames>Fletcher RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2212-8778</gtr:issn><gtr:outcomeId>5a578bb5adec03.46480132</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F09D79B-7A75-4F0C-BF02-E6616BFCA4F2</gtr:id><gtr:title>Dorothy Hodgkin Lecture 2014. Understanding genes identified by genome-wide association studies for type 2 diabetes.</gtr:title><gtr:parentPublicationTitle>Diabetic medicine : a journal of the British Diabetic Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/683c3206afadea563aa753fcbd3ff3dc"><gtr:id>683c3206afadea563aa753fcbd3ff3dc</gtr:id><gtr:otherNames>Rutter GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0742-3071</gtr:issn><gtr:outcomeId>5460fd74af9aa0.86172423</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B120C924-B6DA-45E4-8E46-C787F33E0A18</gtr:id><gtr:title>Loss of Liver Kinase B1 (LKB1) in Beta Cells Enhances Glucose-stimulated Insulin Secretion Despite Profound Mitochondrial Defects.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0366aa00e131b245725b229e747aedc7"><gtr:id>0366aa00e131b245725b229e747aedc7</gtr:id><gtr:otherNames>Swisa A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>5675e7d7454a6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9558355E-BB34-4D82-8257-1CED33F436A1</gtr:id><gtr:title>Optical control of insulin release using a photoswitchable sulfonylurea.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a477df8754c6ae6088f89cfa0aa69d6"><gtr:id>6a477df8754c6ae6088f89cfa0aa69d6</gtr:id><gtr:otherNames>Broichhagen J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5460fd75874a74.52673614</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D8A5A93-534D-4CE4-A245-A87F90879626</gtr:id><gtr:title>eZinCh-2: A Versatile, Genetically Encoded FRET Sensor for Cytosolic and Intraorganelle Zn(2+) Imaging.</gtr:title><gtr:parentPublicationTitle>ACS chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8fe31966993dd9c3003fd3c22b9896c4"><gtr:id>8fe31966993dd9c3003fd3c22b9896c4</gtr:id><gtr:otherNames>Hessels AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1554-8929</gtr:issn><gtr:outcomeId>56c458e9c8c295.01408818</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>639355D5-CBBF-437F-9ED2-FA1A43B5C3D2</gtr:id><gtr:title>Selective disruption of Tcf7l2 in the pancreatic ? cell impairs secretory function and lowers ? cell mass.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f40e1e64032af61ab455c03a6977b343"><gtr:id>f40e1e64032af61ab455c03a6977b343</gtr:id><gtr:otherNames>Mitchell RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>5460fd7c53fb12.41818825</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4EF5102E-592C-4375-B47A-0F0183C123DF</gtr:id><gtr:title>Beta Cell Hubs Dictate Pancreatic Islet Responses to&amp;nbsp;Glucose.</gtr:title><gtr:parentPublicationTitle>Cell metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c7cf81304cde387c0ee09db1d798661"><gtr:id>7c7cf81304cde387c0ee09db1d798661</gtr:id><gtr:otherNames>Johnston NR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1550-4131</gtr:issn><gtr:outcomeId>585d4025300dc9.56329413</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF76BF32-9C5F-47FD-9C4A-036337C1043C</gtr:id><gtr:title>Limited impact on glucose homeostasis of leptin receptor deletion from insulin- or proglucagon-expressing cells.</gtr:title><gtr:parentPublicationTitle>Molecular metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fde388bc9738446a5595b37b05ebe886"><gtr:id>fde388bc9738446a5595b37b05ebe886</gtr:id><gtr:otherNames>Soedling H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2212-8778</gtr:issn><gtr:outcomeId>56c458e94f7b60.92781787</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2CA162B1-F6D9-4C25-90FE-12F7288DA728</gtr:id><gtr:title>Potential role in insulin secretion of Type 2 diabetes GWAS variants at the ARAP1/CENTD2 locus</gtr:title><gtr:parentPublicationTitle>DIABETIC MEDICINE</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8936bcb9e90d1e791b1e0dd558ead159"><gtr:id>8936bcb9e90d1e791b1e0dd558ead159</gtr:id><gtr:otherNames>Hu M.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0742-3071</gtr:issn><gtr:outcomeId>54624ac9227046.68908074</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC7B0EFB-5A69-45A3-B14F-E8CA49006EFB</gtr:id><gtr:title>Decreased STARD10 Expression Is Associated with Defective Insulin Secretion in Humans and Mice.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f868773cfa6b630a663c3a8b84de1f8a"><gtr:id>f868773cfa6b630a663c3a8b84de1f8a</gtr:id><gtr:otherNames>Carrat GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>5a2fcd11a35b64.27082567</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0CE377ED-CC01-4FB9-9E57-42EA315B75F0</gtr:id><gtr:title>Divergent effects of liraglutide, exendin-4, and sitagliptin on beta-cell mass and indicators of pancreatitis in a mouse model of hyperglycaemia.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0bf5f7ce08ed8d2bbc6eceed47ab7099"><gtr:id>0bf5f7ce08ed8d2bbc6eceed47ab7099</gtr:id><gtr:otherNames>Mondragon A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5460fd7486c139.78392219</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9CDD1CD9-3FB2-4C3D-8A48-9F81BD1A081F</gtr:id><gtr:title>The transcription factoris required for pancreatic ? cell identity, glucose-regulated ATP synthesis, and Cadynamics in adult mice.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f40e1e64032af61ab455c03a6977b343"><gtr:id>f40e1e64032af61ab455c03a6977b343</gtr:id><gtr:otherNames>Mitchell RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>5a578be8a5c656.38169699</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F1C37FD-D986-4769-BF8A-E33E7139F0AB</gtr:id><gtr:title>Cell type-specific deletion in mice reveals roles for PAS kinase in insulin and glucagon production.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b3638fc82092488ecc480b6af0b9f6d8"><gtr:id>b3638fc82092488ecc480b6af0b9f6d8</gtr:id><gtr:otherNames>Semplici F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>585d589951bb08.25322507</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB9E1AC4-ECD2-4184-88D2-EB6398C2E949</gtr:id><gtr:title>Proglucagon Promoter Cre-Mediated AMPK Deletion in Mice Increases Circulating GLP-1 Levels and Oral Glucose Tolerance.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/065c1ac8a903ebffde5075e5954dfa70"><gtr:id>065c1ac8a903ebffde5075e5954dfa70</gtr:id><gtr:otherNames>Sayers SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5aa16cd69dd998.85939935</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA0F78F6-472C-457C-AF39-0D4C8A3752A2</gtr:id><gtr:title>Optical Control of Insulin Secretion Using an Incretin Switch.</gtr:title><gtr:parentPublicationTitle>Angewandte Chemie (International ed. in English)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a477df8754c6ae6088f89cfa0aa69d6"><gtr:id>6a477df8754c6ae6088f89cfa0aa69d6</gtr:id><gtr:otherNames>Broichhagen J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1433-7851</gtr:issn><gtr:outcomeId>56c458ea52ab06.28265910</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41D67114-2854-4844-B012-8E6C89E5957F</gtr:id><gtr:title>Pancreatic alpha cell-selective deletion of Tcf7l2 impairs glucagon secretion and counter-regulatory responses to hypoglycaemia in mice.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f817dce2c86b25c911dd61faa4b09d11"><gtr:id>f817dce2c86b25c911dd61faa4b09d11</gtr:id><gtr:otherNames>da Silva Xavier G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>5aa165cd9c0899.29069930</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/K001981/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>